Author Tammy Adler Foeller clearly explains that the opioid crisis did not begin on the streets. It began through systems, messaging, and misplaced trust in American healthcare.

Harm reduction meets people where they are - without requiring abstinence as the starting point. Dr. Andrew Tatarsky's article explains how that shift expands treatment access and improves outcomes.

Belinda Morey explores how GLP-1 medications, long-acting implants, artificial intelligence, virtual reality, and telehealth are reshaping addiction treatment in 2026. By targeting the biology of cravings and increasing consistency and accessibility, these innovations are offering new hope for sustainable recovery — while reinforcing that medication and technology work best when paired with therapy, support, and daily commitment.